T. Rowe Price Associates’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$245M Sell
16,147,922
-1,607,376
-9% -$24.4M 0.03% 391
2025
Q1
$297M Buy
17,755,298
+270,488
+2% +$4.52M 0.04% 349
2024
Q4
$330M Sell
17,484,810
-15,023,104
-46% -$283M 0.04% 330
2024
Q3
$611M Buy
32,507,914
+717,047
+2% +$13.5M 0.07% 247
2024
Q2
$601M Sell
31,790,867
-136,451
-0.4% -$2.58M 0.07% 238
2024
Q1
$519M Buy
31,927,318
+168,161
+0.5% +$2.73M 0.06% 273
2023
Q4
$402M Buy
31,759,157
+260,873
+0.8% +$3.3M 0.05% 291
2023
Q3
$429M Sell
31,498,284
-2,772,160
-8% -$37.7M 0.06% 259
2023
Q2
$588M Sell
34,270,444
-4,110,443
-11% -$70.6M 0.08% 225
2023
Q1
$535M Buy
38,380,887
+114,878
+0.3% +$1.6M 0.08% 235
2022
Q4
$512M Buy
38,266,009
+2,172,770
+6% +$29.1M 0.08% 226
2022
Q3
$430M Sell
36,093,239
-6,616,710
-15% -$78.8M 0.07% 247
2022
Q2
$544M Buy
42,709,949
+736,123
+2% +$9.37M 0.07% 272
2022
Q1
$543M Buy
41,973,826
+3,126,038
+8% +$40.4M 0.05% 312
2021
Q4
$615M Buy
38,847,788
+1,156,383
+3% +$18.3M 0.06% 315
2021
Q3
$735M Buy
37,691,405
+3,647,016
+11% +$71.1M 0.07% 278
2021
Q2
$775M Sell
34,044,389
-4,812,801
-12% -$110M 0.07% 269
2021
Q1
$714M Sell
38,857,190
-2,158,136
-5% -$39.7M 0.07% 281
2020
Q4
$611M Buy
41,015,326
+262,020
+0.6% +$3.9M 0.06% 293
2020
Q3
$457M Buy
40,753,306
+2,654
+0% +$29.8K 0.05% 316
2020
Q2
$323M Buy
40,750,652
+3,343,169
+9% +$26.5M 0.04% 361
2020
Q1
$302M Sell
37,407,483
-4,086,812
-10% -$33M 0.05% 340
2019
Q4
$522M Sell
41,494,295
-2,443,745
-6% -$30.7M 0.07% 296
2019
Q3
$392M Buy
43,938,040
+1,143,337
+3% +$10.2M 0.06% 321
2019
Q2
$366M Buy
42,794,703
+305,410
+0.7% +$2.61M 0.05% 335
2019
Q1
$323M Buy
42,489,293
+2,552,355
+6% +$19.4M 0.05% 353
2018
Q4
$330M Buy
39,936,938
+2,566,391
+7% +$21.2M 0.06% 308
2018
Q3
$370M Buy
37,370,547
+94,649
+0.3% +$938K 0.05% 338
2018
Q2
$365M Buy
37,275,898
+397,507
+1% +$3.89M 0.06% 333
2018
Q1
$343M Buy
36,878,391
+841,118
+2% +$7.82M 0.05% 338
2017
Q4
$343M Buy
36,037,273
+179,080
+0.5% +$1.7M 0.06% 341
2017
Q3
$371M Buy
35,858,193
+859,699
+2% +$8.89M 0.06% 317
2017
Q2
$289M Buy
34,998,494
+419,828
+1% +$3.47M 0.05% 356
2017
Q1
$249M Buy
34,578,666
+731,097
+2% +$5.26M 0.05% 381
2016
Q4
$242M Buy
33,847,569
+866,709
+3% +$6.19M 0.05% 381
2016
Q3
$240M Buy
32,980,860
+4,241,455
+15% +$30.9M 0.05% 375
2016
Q2
$168M Buy
28,739,405
+1,049,977
+4% +$6.15M 0.04% 449
2016
Q1
$176M Buy
27,689,428
+41,203
+0.1% +$262K 0.04% 421
2015
Q4
$177M Sell
27,648,225
-318,081
-1% -$2.04M 0.04% 429
2015
Q3
$163M Buy
27,966,306
+1,828,234
+7% +$10.6M 0.04% 455
2015
Q2
$228M Buy
26,138,072
+46,363
+0.2% +$405K 0.05% 413
2015
Q1
$208M Buy
26,091,709
+2,964,730
+13% +$23.7M 0.04% 430
2014
Q4
$179M Buy
23,126,979
+3,473,893
+18% +$27M 0.04% 459
2014
Q3
$127M Sell
19,653,086
-680,660
-3% -$4.41M 0.03% 536
2014
Q2
$171M Sell
20,333,746
-920,101
-4% -$7.73M 0.04% 483
2014
Q1
$143M Sell
21,253,847
-1,297,756
-6% -$8.71M 0.03% 520
2013
Q4
$141M Buy
22,551,603
+2,571,128
+13% +$16.1M 0.03% 512
2013
Q3
$86.9M Buy
19,980,475
+2,535,935
+15% +$11M 0.02% 630
2013
Q2
$77.1M Buy
+17,444,540
New +$77.1M 0.02% 644